Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

Signal Transduct Target Ther. 2020 Nov 24;5(1):276. doi: 10.1038/s41392-020-00407-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage*
  • Adrenal Cortex Hormones / adverse effects
  • Adult
  • Aged
  • COVID-19 / epidemiology
  • COVID-19 / pathology
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • China / epidemiology
  • Female
  • Humans
  • Immunoglobulins / administration & dosage*
  • Immunoglobulins / adverse effects
  • Male
  • Middle Aged
  • Pandemics
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / pathogenicity
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones
  • Immunoglobulins